NewsRoom Articles - Page 571 of 602

WednesdayNov 08, 2017 2:41 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners

High-margin licensing royalties of 5-10% of gross sales of its patented bioscience technology and process are an attractive valuation builder; LXRP sees more licensing opportunities in 2018 LXRP’s technology is patented in the U.S. and Australia; company has national/regional filings pending in 44 countries Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners. LXRP has also expanded its process of improved and faster inhalation by the body of fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) in pain…

TuesdayNov 07, 2017 3:25 pm

Marijuana Company of America, Inc. (MCOA) Building Momentum as Legalization Push Gains Steam

MCOA is building a role in cannabis and hemp industry through strategic network Growing legal cannabis markets estimated to reach $37.3 billion by 2024 Hemp market estimates foresee growth into the billions by 2020 Amid the drive of several states to put the legal framework for recreational marijuana use into place, Marijuana Company of America, Inc. (OTC: MCOA) is building upon its vertically integrated business strategy by taking a unique approach to how companies within the industry position themselves in the marketplace. On January 1, recreational marijuana use will become legal in California (http://cnw.fm/xr0lW), which will complete the regulatory picture…

TuesdayNov 07, 2017 11:57 am

ChineseInvestors.com, Inc.’s (CIIX) Diversity Drives Success; Aims Even Higher for FY2018

Launching its Chinese Daily Video News Broadcast from NYSE on cryptocurrency news in 1Q2018 CIIX sets FY2018 goals of greater than 100% sales increase, reduced costs, and profitability Consilium Global Research projects CIIX to reach revenues of $14.8 million by FY2020 at a compounded annual growth rate (CAGR) of nearly 100% CIIX reports FY2017 YOY operating sales gain of 76% ChineseInvestors.com, Inc. (OTCQB: CIIX) is a diverse company with goals set by Warren Wang, company founder and CEO, of a 100% gain in sales in FY2018 after achieving a 76% YOY increase in operating revenues in FY2017. The goal in…

TuesdayNov 07, 2017 11:05 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Supplements Popular Beverage with Legal CBD

Unique patented drug delivery platform Active in world’s largest beverage market Technology that compliments rather than competes with CBD companies An old and popular beverage is being supplemented in a healthy, flavorful way now that Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is on the scene. Having increased its ownership stake in PoViva Tea, LLC from 51% to 100%, the innovative drug delivery biotech plans to apply its patented DehydraTECH™ technology to supplement a range of black teas with cannabidiol (CBD) from hemp. After water, tea is the most widely consumed beverage in the world and is an ideal adjuvant…

MondayNov 06, 2017 2:14 pm

Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level

Skinvisible already develops hemp-based products and is expanding its product line of cannabis-based topical product market Research verifies its Invisicare® technology improves the penetration rate and boosts the availability of the cannabis ingredients in both topical and transdermal products Skinvisible has entered a strategic partnership with Canopy Growth Corporation for the sale of its product formulations in the Canadian market Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. (OTCQB: SKVI), has a potentially wide range of applications in the cannabis market. The technology improves the delivery of pharmaceutical and medicinal compounds to and through the skin, which…

MondayNov 06, 2017 11:20 am

PotNetwork Holding Inc. (POTN) Positioned for a Bright Future in the CBD Market

PotNetwork’s subsidiary, Diamond CBD, reports record sales of $1.76 million in August 2017 Acknowledged industry experts appointed to advisory board New line of CBD-infused honey products launched in October 2017 The hemp-derived cannabidiol (CBD) market is projected to show phenomenal growth over the next few years. The Hemp Business Journal has projected a compound annual growth rate (CAGR) of 53 percent for CBD products derived from hemp, estimating this market to be worth $1.8 billion by 2020 (http://cnw.fm/qf0A1). PotNetwork Holding, Inc. (OTC: POTN) is in a strong position to take advantage of this growth through its subsidiary, Diamond CBD, with…

ThursdayNov 02, 2017 3:27 pm

AV1 Group, Inc. (AVOP) is “One to Watch”

Strategic approach to cannabis and hemp industry through networking architecture Legal marijuana markets estimated to reach $22.6 billion by 2021 Branded “hempSMART Brain™” CBD product is first to be offered by direct market Wellness industry is now $1.9 trillion per year with huge growth potential AV1 Group, Inc. (OTC: AVOP) is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint…

ThursdayNov 02, 2017 2:21 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies

6 patents filed for pain management, eating disorders and epilepsy Additional patents underway for PTSD, depression, Alzheimer’s and Parkinson’s disease Revenue potential of each cannabis-based therapy could fetch between $100 million to $500 million India Globalization Capital (NYSE AMERICAN: IGC) is a first mover in developing a portfolio of products using cannabis-based “combination therapies” for the treatment of Alzheimer’s, cachexia, pain, and other life-altering conditions. The company’s most recent research and development focus continues to be on readying a line of cannabis-based products targeting Alzheimer’s disease utilizing novel data (http://cnw.fm/1hUKu). This cannabis-based combination therapy shows promise for Alzheimer’s sufferers, says…

WednesdayNov 01, 2017 1:05 pm

AppSwarm, Inc. (SWRM) Leverages Technology and Business Expertise to Enter the Cannabis Market Through SinglePoint, Inc. (SING) Joint Venture

SWRM has four diversified revenue streams as it seeks to grow in multi-platform games, offers its expertise to develop new cannabis apps under SinglePoint’s SingleSeed subsidiary brand SWRM managers project company FY2018 volume of $6 million-$7 million Cannabis market projected to reach $50 billion by 2025 AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING). The two companies have announced a letter of agreement to roll-out cannabis industry mobile apps (http://cnw.fm/Vhx75). They said they would generate their first…

TuesdayOct 31, 2017 2:54 pm

Strategic Acquisition Enables Grey Cloak Tech, Inc.’s (GRCK) Development in Two Industries

Through its acquisition of Eqova Life Sciences, Grey Cloak has successfully entered the CBD oil industry At the same time, the company remains focused on furthering the effectiveness of its digital advertising fraud prevention software Both the CBD oil and the digital marketing fraud prevention markets are expected to grow exponentially throughout 2018 On October 24, 2017, Grey Cloak Tech, Inc. (OTCQB: GRCK) announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products. The company sent a letter of intent pertaining to the acquisition in September. Eqova, a company…

News and publishing service for cannabis related companies

Contact us: 512.354.7000